Similarly, high levels of ABCG2, known as breast cancer resistance protein (BCRP), have been associated with MDR in NSCLC, melanoma, breast, colorectal, ovarian, and gastric cancers [5]. The gene discussed is ABCG2; the disease is melanoma.